Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7633)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2012 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan Q, Peppelenbosch MP, Janssen HL, Knegt RJ. Telaprevir/boceprevir era: From bench to bed and back. World J Gastroenterol 2012; 18(43): 6183-6188 [PMID: 23180937 DOI: 10.3748/wjg.v18.i43.6183] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i43/6183.htm |
| Number | Citing Articles |
| 1 |
Joseph G. Arthur, Hien T. Tran, Philip Aston. Feasibility of parameter estimation in hepatitis C viral dynamics models. Journal of Inverse and Ill-posed Problems 2017; 25(1): 69 doi: 10.1515/jiip-2014-0048
|
| 2 |
Ashley N. Matthew, Florian Leidner, Gordon J. Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N. Rusere, Debra A. Ragland, Janet L. Paulsen, Kristina Prachanronarong, Djade I. Soumana, Ellen A. Nalivaika, Nese Kurt Yilmaz, Akbar Ali, Celia A. Schiffer. Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. Chemical Reviews 2021; 121(6): 3238 doi: 10.1021/acs.chemrev.0c00648
|
| 3 |
Bodee Nutho, Adrian J. Mulholland, Thanyada Rungrotmongkol. Quantum Mechanics/Molecular Mechanics (QM/MM) Calculations Support a Concerted Reaction Mechanism for the Zika Virus NS2B/NS3 Serine Protease with Its Substrate. The Journal of Physical Chemistry B 2019; 123(13): 2889 doi: 10.1021/acs.jpcb.9b02157
|
| 4 |
Marta Denel-Bobrowska, Agnieszka B. Olejniczak. Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020). European Journal of Medicinal Chemistry 2022; 231: 114136 doi: 10.1016/j.ejmech.2022.114136
|
| 5 |
Daniele Serranti, Giuseppe Indolfi, Massimo Resti. New treatments for chronic hepatitis C: An overview for paediatricians. World Journal of Gastroenterology 2014; 20(43): 15965-15974 doi: 10.3748/wjg.v20.i43.15965
|
| 6 |
Antonio Bensussen, Elena R. Álvarez-Buylla, José Díaz. SARS-CoV-2 Nsp5 Protein Causes Acute Lung Inflammation, A Dynamical Mathematical Model. Frontiers in Systems Biology 2021; 1 doi: 10.3389/fsysb.2021.764155
|
| 7 |
Selin Zeynep Sunar, Tayfun Acar, Fikrettin Sahin. Chemically Peptide Synthesis and Role of Arginine and Lysine in the Antimicrobial and Antiviral Activity of Synthetic Peptides: A Comprehensive Review. Peptide Science 2024; 116(5) doi: 10.1002/pep2.24368
|
| 8 |
Nasim Bakhtiyari, Sepideh Parvizpour, Yosef Masoudi-Sobhanzadeh, Ali Masoudi-Nejad. Computational-based strategies to deal with liver injuries induced by the repurposed drugs against SARS-CoV-2. Informatics in Medicine Unlocked 2023; 41: 101336 doi: 10.1016/j.imu.2023.101336
|
| 9 |
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules 2020; 25(23): 5695 doi: 10.3390/molecules25235695
|
| 10 |
Zhilan Zhou, Jifa Zhang, Enda Zhou, Changyu Ren, Jiaxing Wang, Yuxi Wang. Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. European Journal of Medicinal Chemistry 2022; 240: 114595 doi: 10.1016/j.ejmech.2022.114595
|
| 11 |
Kowit Hengphasatporn, Yasuteru Shigeta. Advances in Methods and Applications of Quantum Systems in Chemistry, Physics, and Biology. Progress in Theoretical Chemistry and Physics 2024; 34: 271 doi: 10.1007/978-3-031-52078-5_16
|
| 12 |
Steven J. Coats, Ethel C. Garnier-Amblard, Franck Amblard, Maryam Ehteshami, Sheida Amiralaei, Hongwang Zhang, Longhu Zhou, Sebastien R.L. Boucle, Xiao Lu, Lavanya Bondada, Jadd R. Shelton, Hao Li, Peng Liu, Chengwei Li, Jong Hyun Cho, Satish N. Chavre, Shaoman Zhou, Judy Mathew, Raymond F. Schinazi. Chutes and ladders in hepatitis C nucleoside drug development. Antiviral Research 2014; 102: 119 doi: 10.1016/j.antiviral.2013.11.008
|
| 13 |
Shagufta Kamal, Asif Shahzad, Kanwal Rehman, Komal Tariq, Muhammad Sajid Hamid Akash, Muhammad Imran, Mohammed Ali Assiri. Therapeutic Intervention of Serine Protease Inhibitors against
Hepatitis C Virus. Current Medicinal Chemistry 2024; 31(15): 2052 doi: 10.2174/0109298673234823230921090431
|
| 14 |
Longhu Zhou, Hong-wang Zhang, Sijia Tao, Leda Bassit, Tony Whitaker, Tamara R. McBrayer, Maryam Ehteshami, Sheida Amiralaei, Ugo Pradere, Jong Hyun Cho, Franck Amblard, Drew Bobeck, Mervi Detorio, Steven J. Coats, Raymond F. Schinazi. β-d-2′-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5′-Triphosphate Forms. Journal of Medicinal Chemistry 2015; 58(8): 3445 doi: 10.1021/jm501874e
|
| 15 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 16 |
Wenhui Wang, Qiuwei Pan, Gwenny M. Fuhler, Ron Smits, Maikel P. Peppelenbosch. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. Journal of Gastroenterology 2017; 52(4): 419 doi: 10.1007/s00535-016-1299-5
|
| 17 |
Anna Mazurkiewicz-Pisarek, Joanna Baran, Tomasz Ciach. Antimicrobial Peptides: Challenging Journey to the Pharmaceutical, Biomedical, and Cosmeceutical Use. International Journal of Molecular Sciences 2023; 24(10): 9031 doi: 10.3390/ijms24109031
|
| 18 |
Carol Stanciu, Cristina Maria Muzica, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Laura Huiban, Stefan Chiriac, Tudor Cuciureanu, Anca Trifan. An update on direct antiviral agents for the treatment of hepatitis C. Expert Opinion on Pharmacotherapy 2021; 22(13): 1729 doi: 10.1080/14656566.2021.1921737
|
| 19 |
Wenlian Li, Hongzong Si, Yang Li, Cuizhu Ge, Fucheng Song, Xiuting Ma, Yunbo Duan, Honglin Zhai. 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase. Journal of Molecular Structure 2016; 1117: 227 doi: 10.1016/j.molstruc.2016.03.073
|
| 20 |
Nathalie Alazard-Dany, Solène Denolly, Bertrand Boson, François-Loïc Cosset. Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets. Viruses 2019; 11(1): 30 doi: 10.3390/v11010030
|
| 21 |
Mohamad S. Hakim, Xinying Zhou, Yijin Wang, Maikel P. Peppelenbosch, Qiuwei Pan. Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon response. AIMS Molecular Science 2014; 1(1): 49 doi: 10.3934/molsci.2014.1.49
|
| 22 |
Xinying Zhou, Robert A. de Man, Robert J. de Knegt, Herold J. Metselaar, Maikel P. Peppelenbosch, Qiuwei Pan. Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review. Reviews in Medical Virology 2013; 23(5): 295 doi: 10.1002/rmv.1751
|
| 23 |
Satish Kumar, P. K. Santra, R. C. Aryan. SYNTHESIS CHARACTERIZATION AND DOCKING STUDY OF HCV NS3/4A PROTEASE INHIBITOR MOLECULES. INDIAN DRUGS 2020; 57(05): 19 doi: 10.53879/id.57.05.12295
|
| 24 |
Fabao Zhao, Na Liu, Peng Zhan, Xuemei Jiang, Xinyong Liu. Discovery of HCV NS5B thumb site I inhibitors: Core-refining from benzimidazole to indole scaffold. European Journal of Medicinal Chemistry 2015; 94: 218 doi: 10.1016/j.ejmech.2015.03.012
|